- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01546480
From Acute to Chronic Postoperative Pain in Patients for Elective Cholecystectomy. Immunological Tests
Chronic Pain after Cholecystectomy is a well known problem. One theory is that it is due to persisting inflammation.
The purpose of the study is to measure inflammatory factors in cerebrospinal fluid and blod at patients 12 months after the operation.
DNA-samples are collected to examine genetical factors, important for perception of pain, and the development of chronic pain.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Odense, Denmark, 5000
- Odense University Hospital
-
Vejle, Denmark, 7100
- Lillebælt Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Patients in group 1 and 2 previously participated in a study of postcholecystectomy pain.
Patients in group 3 are patients scheduled for elective surgery in spinal anesthesia at the participating centres.
Description
Group 1:
Inclusion Criteria:
- Unexplained abdominal pain 12 months after elective cholecystectomy
Exclusion Criteria:
- Immunosuppressive treatment (NSAID excepted)
- Anticoagulant treatment
Group 2:
Inclusion Criteria:
- No pain 12 months after elective cholecystectomy
Exclusion Criteria:
- Immunosuppressive treatment (NSAID excepted)
- Anticoagulant treatment
Group 3:
Inclusion Criteria:
- Elective operation in spinal anesthesia or
- Or healthy volunteers accepting samples of blod, cerebral spinal fluid and saliva, to be collected
Exclusion Criteria:
- Acute or chronic pain condition
- Immunosuppressive treatment (NSAID excepted)
- Previous abdominal operation
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Pain patients
Patients with unexplained chronic abdominal pain 12 months after elective cholecystectomy
|
|
Operated painfree Patients
Painfree patients 12 months after elective cholecystectomy
|
|
Nonoperated painfree patients
Painfree patients with no previous abdominal operation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spinal interleukine levels
Time Frame: 12 months
|
12 months after surgery
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood interleukine levels
Time Frame: 12 Months
|
12 Months
|
|
|
spinal enzyme levels
Time Frame: 12 months
|
12 months after surgery
|
12 months
|
|
Blood enzyme levels
Time Frame: 12 months
|
12 months after surgery
|
12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ImmT
- 119 (hhh)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.